Loading...
Market
What will be the primary application of Neuralink's N1 Implant by Dec 31, 2025?
2
Resolution / Starting Odds
Assistive technology for paralysis • 25%
Cognitive enhancement • 25%
Medical treatment for neurological disorders • 25%
Other • 25%
Neuralink's final trial report or scientific publications
Story
Neuralink Launches Trial of N1 Brain Implant to Control Robotic Arm in Paralyzed Patients
Nov 25, 2024, 07:45 PM
Neuralink announced the launch of a new feasibility study, named 'CONVOY', to extend brain-computer interface (BCI) control using the N1 Implant to an investigational assistive robotic arm. The study aims to evaluate the safety and effectiveness of the implant in patients with quadriplegia, allowing them to control external devices with their thoughts. This development represents an important step towards restoring physical freedom to individuals with paralysis.
View original story
Similar markets
Medical rehabilitation • 25%
Gaming • 25%
Communication • 25%
Other • 25%
Medical (e.g., helping paralyzed individuals) • 25%
Gaming • 25%
Communication • 25%
Other • 25%
Gaming and digital device control • 25%
Medical applications • 25%
Research and development • 25%
Other • 25%
Gaming • 25%
Virtual Reality • 25%
Augmented Reality • 25%
Other • 25%
Communication enhancement for ALS patients • 25%
Cognitive enhancement for general users • 25%
Control of tech devices like Apple Vision Pro • 25%
Medical research and trials • 25%
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Other • 25%
Medical rehabilitation • 25%
Gaming and entertainment • 25%
Industrial and design applications • 25%
Other • 25%
Full success • 25%
Partial success • 25%
No success • 25%
Trial discontinued • 25%
Restoring eyesight to a blind individual • 25%
Enhancing vision for partially sighted individuals • 25%
Other medical applications • 25%
No application by end of 2024 • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Infrared vision capability • 25%
Ultraviolet vision capability • 25%
Both infrared and ultraviolet vision capabilities • 25%
Neither capability • 25%
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%